Fulvestrant
FDA Approved: * March 4, 2019Pharm Company: * AMNEAL PHARMS CO
Category: Cancer
Fulvestrant, sold under the brand name Faslodex among others, is a medication used to treat hormone receptor (HR)-positive metastatic breast cancer in postmenopausal women with disease progression as well as HR-positive, HER2-negative advanced breast cancer in combination with palbociclib in women with disease progression after endocrine therapy.[2] It is given by injection into a muscle.[3] Fulvestrant is a selective estrogen receptor degrader (SERD) and was f... [wikipedia]
* May have multiple approval dates, manufacturers, or labelers.2 Discussions
Dosage List
Related Brands
Drugs with the same active ingredientsPopular Topics
Fulvestrant and Belviqside
1 REPLY
I have stage IV breast cancer. After being unable to control cancer with different endocrine therapy my oncologist put m...